Modulation of Interleukins in Sepsis-Associated Clotting Disorders
نویسندگان
چکیده
منابع مشابه
Bleeding and Clotting Disorders
Dental health care workers are increasingly called upon to provide quality dental care to individuals whose bleeding and clotting mechanisms have been altered by inherited or acquired diseases. This provides an opportunity for the dentist who is trained in the recognition of oral and systemic signs of altered hemostasis to assist in the diagnosis of the underlying condition. A number of dental ...
متن کاملMonocyte urokinase expression: modulation by interleukins.
This study delineates the regulatory effect of interleukin-1 (IL-1) and interleukin-2 (IL-2) on monocyte plasminogen activator (PA) activity. Mononuclear phagocytes regulate net PA activity by modulating the expression of urokinase-type PA (uPA) and a specific plasminogen activator inhibitor, PAI-2. To understand the regulation of mononuclear phagocyte PA activity, it is important to compare th...
متن کاملRespiratory disorders associated with stroke and the role of physiotherapy in the treatment of these disorders
Introduction Stroke is a common neurological disease that can have a negative effect on all parts of the body. The respiratory system is one of the parts of the body that may be damaged by stroke. The respiratory disorders caused by stroke can occur in all three sections of the breath; including metabolic respiration, behavioral respiration and emotional respiration. Disorder in each of these ...
متن کاملPLATELET DISORDERS Platelets in sepsis
Platelets are circulating blood cells that will normally not interact with the intact vessel wall but that may swiftly respond to vascular disruption by adhering to subendothelial structures, followed by interaction with each other, thereby forming a platelet aggregate. The activated platelet (phospholipid) membrane may form a suitable surface on which further coagulation activation may occur. ...
متن کاملBleeding and clotting disorders in pediatric liver disease.
The coagulopathy of liver disease in pediatric patients presents an unusual set of challenges. Little pediatric data have been published, so this review is based largely on adult studies. There is a precarious balance between deficiencies of clotting factors and anticoagulation factors in liver disease that result in abnormal prothrombin time (PT) and activated partial thromboplastin time (aPTT...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical and Applied Thrombosis/Hemostasis
سال: 2016
ISSN: 1076-0296,1938-2723
DOI: 10.1177/1076029616659696